Validation of a clinical-radiographic score to assess the probability of pulmonary tuberculosis in suspect patients with negative sputum smears.
PLoS One 2011;
6:e18486. [PMID:
21483690 PMCID:
PMC3071732 DOI:
10.1371/journal.pone.0018486]
[Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2010] [Accepted: 03/02/2011] [Indexed: 11/30/2022] Open
Abstract
Background
Clinical suspects of pulmonary tuberculosis in which the sputum smears are
negative for acid fast bacilli represent a diagnostic challenge in resource
constrained settings. Our objective was to validate an existing
clinical-radiographic score that assessed the probability of smear-negative
pulmonary tuberculosis (SNPT) in high incidence settings in Peru.
Methodology/Principal Findings
We included in two referral hospitals in Lima patients with clinical
suspicion of pulmonary tuberculosis and two or more negative sputum smears.
Using a published but not externally validated score, patients were
classified as having low, intermediate or high probability of pulmonary
tuberculosis. The reference standard for the diagnosis of tuberculosis was a
positive sputum culture in at least one of 2 liquid (MGIT or Middlebrook
7H9) and 1 solid (Ogawa) media. Prevalence of tuberculosis was calculated in
each of the three probability groups.
684 patients were included. 184 (27.8%) had a diagnosis of pulmonary
tuberculosis. The score did not perform well in patients with a previous
history of pulmonary tuberculosis. In patients without, the prevalence of
tuberculosis was 5.1%, 31.7% and 72% in the low,
intermediate and high probability group respectively. The area under de ROC
curve was 0.76 (95% CI 0.72–0.80) and scores ≥6 had a
positive LR of 10.9.
Conclusions/Significance
In smear negative suspects without previous history of tuberculosis, the
clinical-radiographic score can be used as a tool to assess the probability
of pulmonary tuberculosis and to guide the decision to initiate or defer
treatment or to requesting additional tests.
Collapse